Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Autran

Showing results (121-130 of 201) with videos related to

Pageof 21
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Vaccine|December 17, 2013
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipientsNathalie Dhédin, Anne Krivine, Nicole Le Corre, et al.
AIDS (London, England)|November 16, 2010
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccineLaura Papagno, Galit Alter, Lambert Assoumou, et al.
AIDS (London, England)|June 27, 2008
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)Brigitte Autran, Robert L Murphy, Dominique Costagliola, et al.
AIDS (London, England)|August 11, 2018
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patientsNathalie Colin de Verdiere, Christine Durier, Assia Samri, et al.
Vaccine|October 30, 2012
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trialNicole Le Corre, Fréderic Thibault, Claire Pouteil Noble, et al.
Open Forum Infectious Diseases|January 1, 2020
Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated AdultsAnders Boyd, Franck Boccara, Jean-Luc Meynard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2013
Differential impact of age and cytomegalovirus infection on the γδ T cell compartmentAntoine Roux, Gisèle Mourin, Martin Larsen, et al.
AIDS (London, England)|December 3, 2009
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapyAmélie Guihot, Roland Tubiana, Guillaume Breton, et al.
Blood|April 25, 2009
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activityJorge R Almeida, Delphine Sauce, David A Price, et al.
Pageof 21

Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Vaccine|December 17, 2013
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipientsNathalie Dhédin, Anne Krivine, Nicole Le Corre, et al.
AIDS (London, England)|November 16, 2010
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccineLaura Papagno, Galit Alter, Lambert Assoumou, et al.
AIDS (London, England)|June 27, 2008
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)Brigitte Autran, Robert L Murphy, Dominique Costagliola, et al.
AIDS (London, England)|August 11, 2018
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patientsNathalie Colin de Verdiere, Christine Durier, Assia Samri, et al.
Vaccine|October 30, 2012
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trialNicole Le Corre, Fréderic Thibault, Claire Pouteil Noble, et al.
Open Forum Infectious Diseases|January 1, 2020
Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated AdultsAnders Boyd, Franck Boccara, Jean-Luc Meynard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2013
Differential impact of age and cytomegalovirus infection on the γδ T cell compartmentAntoine Roux, Gisèle Mourin, Martin Larsen, et al.
AIDS (London, England)|December 3, 2009
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapyAmélie Guihot, Roland Tubiana, Guillaume Breton, et al.
Blood|April 25, 2009
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activityJorge R Almeida, Delphine Sauce, David A Price, et al.
Pageof 21